Free Alerts   Login
Health Care › BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES)

CRBU Stock Price Correlated With Caribou Biosciences Financials

CRBU Stock Price vs. Quarterly
CRBU
Income Statement
Cash Flow
Balance Sheet

CRBU Income Statement

Enable JavaScript and reload
Revenue, Net:
Revenue Per Share:
Cost of Goods & Services Sold:
Gross Profit:
Selling, General & Admin Expense:
Research & Development Expense:
Total Operating Expenses:
Operating Income:
Income Taxes:
Net Income:
Earnings Per Share, Diluted:
Earnings Per Share, Basic:
Shares Outstanding, Basic Avg:
Shares Outstanding, Diluted Avg:
Common Stock Shares Outstanding:

CRBU Cash Flow

Enable JavaScript and reload
Operating Activities Net Income:
Depreciation, Depletion & Amortization:
Change in Accounts Receiveable:
Net Cash from Operations:
Net Cash from Operations Per Share:
Repurchases/Buybacks Common Stock:
Issuance of Long-term Debt:
Cash Dividends Paid:
Net Cash from Financing Activities:
Property, Plant & Equipment Purchases:
Purchases of Businesses, Net of Cash:
Net Cash from Investing Activities:
Net Change in Cash & Equivalents:

CRBU Balance Sheet

Enable JavaScript and reload
Cash and Cash Equivalents:
Short-Term Investments:
Accounts Receivable, Net:
Inventories:
Total Current Assets:
Property, Plant & Equipment, Net:
Total Assets:
Accounts Payable:
Current Portion of Long-Term Debt:
Total Short-Term Liabilities:
Long Term Debt, Non-Current Portion:
Total Long-Term Liabilities:
Total Liabilities:

Major Holders (from 13F filings)

Investment Type
Change
Value (x$1000)
increase or decrease
Partner Fund Management, L.P.
5,012,118 sh
552,335 sh
12%
$26,614
-$1,393
State Street
3,355,292 sh
156,399 sh
5%
$17,817
-$2,272
Avidity Partners Management Lp
2,758,600 sh
-124,000 sh
-4%
$14,648
-$3,455
Rokos Capital Management Llp
2,748,139 sh
 
$14,086
Vanguard Group
2,606,061 sh
52,633 sh
2%
$13,839
-$13,100
Elmwood Wealth Management.
2,364,240 sh
 
$12,554
Pictet Asset Management SA
2,066,176 sh
-487,702 sh
-19%
$10,972
-$5,067
FMR
1,443,823 sh
777 sh
0%
$7,667
-$9,054,665
Morgan Stanley
1,249,248 sh
20,081 sh
2%
$6,632
-$1,088
Geode Capital Management
1,069,624 sh
38,637 sh
4%
$5,680
-$794
FIL
860,666 sh
 
$4,570
Assenagon Asset Management S.A.
843,025 sh
-11,713 sh
-1%
$4,476
-$892
Maverick Capital
652,542 sh
 
$3,465
JPMorgan Chase
602,978 sh
2,881 sh
0%
$3,202
-$567
Tekla Capital Management
567,147 sh
 
$3,012
Memorial Sloan-Kettering Cancer Center
544,196 sh
 
$2,890
Northernrp
529,005 sh
-5,482 sh
-1%
$2,809
-$3,353,769
72 Investment Holdings
474,067 sh
 
$2,517
International Biotechnology Trust Plc
457,892 sh
200,000 sh
78%
$2,427
-$1,617,135
Millennium Management
325,015 sh
84,972 sh
35%
$2

Free historical financial statements for Caribou Biosciences Inc.. See how revenue, income, cash flow, and balance sheet financials have changed over 8 quarters since 2021. Compare with CRBU stock chart to see long term trends.

Data imported from Caribou Biosciences Inc. SEC filings. Check original filings before making any investment decision.